Related Experiment Video
Updated: Feb 26, 2026

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
Taxanes and platinum derivatives impair Schwann cells via distinct mechanisms
Satoshi Imai1, Madoka Koyanagi1, Ziauddin Azimi2,3
1Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Abstract:
Impairment of peripheral neurons by anti-cancer agents, including taxanes and platinum derivatives, has been considered to be a major cause of chemotherapy-induced peripheral neuropathy (CIPN), however, the precise underlying mechanisms are not fully understood. Here, we examined the direct effects of anti-cancer agents on Schwann cells. Exposure of primary cultured rat Schwann cells to paclitaxel (0.01 μM), cisplatin (1 μM), or oxaliplatin (3 μM) for 48 h induced cytotoxicity and reduced myelin basic protein expression at concentrations lower than those required to induce neurotoxicity in cultured rat dorsal root ganglion (DRG) neurons. Similarly, these anti-cancer drugs disrupted myelin formation in Schwann cell/DRG neuron co-cultures without affecting nerve axons. Cisplatin and oxaliplatin, but not paclitaxel, caused mitochondrial dysfunction in cultured Schwann cells. By contrast, paclitaxel led to dedifferentiation of Schwann cells into an immature state, characterized by increased expression of p75 and galectin-3. Consistent with in vitro findings, repeated injection of paclitaxel increased expression of p75 and galectin-3 in Schwann cells within the mouse sciatic nerve. These results suggest that taxanes and platinum derivatives impair Schwan cells by inducing dedifferentiation and mitochondrial dysfunction, respectively, which may be important in the development of CIPN in conjunction with their direct impairment in peripheral neurons.
Insights
Chemotherapy drugs like paclitaxel and cisplatin damage peripheral nerves, causing neuropathy. This study reveals these drugs directly harm Schwann cells, impairing nerve insulation and potentially contributing to chemotherapy-induced peripheral neuropathy.
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of anti-cancer drugs.
- Taxanes and platinum derivatives are known neurotoxic agents, but their precise mechanisms in CIPN are unclear.
- The role of Schwann cells, crucial for peripheral nerve health, in CIPN pathogenesis requires further investigation.
Purpose of the Study:
- To investigate the direct effects of chemotherapy agents on Schwann cells.
- To elucidate the specific mechanisms by which paclitaxel, cisplatin, and oxaliplatin impact Schwann cell function.
- To determine the contribution of Schwann cell impairment to the development of CIPN.
Main Methods:
- Primary rat Schwann cells and co-cultures with dorsal root ganglion (DRG) neurons were exposed to paclitaxel, cisplatin, and oxaliplatin.
- Cytotoxicity, myelin basic protein expression, and myelin formation were assessed.
- Mitochondrial function and Schwann cell differentiation markers (p75, galectin-3) were analyzed.
- In vivo studies involved repeated paclitaxel injection in mice to examine sciatic nerve Schwann cells.
Main Results:
- Chemotherapy agents induced cytotoxicity and reduced myelin basic protein expression in Schwann cells at lower concentrations than those affecting DRG neurons.
- Myelin formation was disrupted in co-cultures without direct axonal damage.
- Cisplatin and oxaliplatin caused mitochondrial dysfunction in Schwann cells.
- Paclitaxel induced Schwann cell dedifferentiation, marked by increased p75 and galectin-3 expression, both in vitro and in vivo.
- In vivo findings confirmed paclitaxel-induced changes in mouse sciatic nerve Schwann cells.
Conclusions:
- Taxanes and platinum derivatives directly impair Schwann cells, contributing to CIPN.
- Paclitaxel induces Schwann cell dedifferentiation, while platinum derivatives cause mitochondrial dysfunction.
- These Schwann cell-specific effects, alongside direct neurotoxicity, are critical in CIPN development.
More Related Videos
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Targeted Cancer Therapies
There are several types of targeted therapies against...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Treatment Resistant Cancers
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

